Pharmaniaga's Buy Of Indonesia Drug-Making Plant To Up Capacity 20%
This article was originally published in PharmAsia News
Executive Summary
The head of Pharmaniaga, Malaysia's largest maker of generic drugs, said the company had agreed to buy an Indonesia manufacturing plant, expected to expand its drug production by 20%.